Search

Review: Phage therapy in the COVID-19 era: Advantages over antibiotics.

Minireview: Considerations for the use of phage therapy in clinical practice, by Gina Suh et al., on behalf of the Antibacterial Resistance Leadership Group.

Review: Phages of phytopathogenic bacteria - high potential but challenging application

Review: Phage therapy for antibiotic-resistant bacterial infections.

Rashedul Islama (Guelph Research and Development Centre, Canada) and colleagues published in Critical Reviews in Food Science and Nutrition a systematic review from basics to omics on bacteriophage applications in poultry production and pro

Graham Hatfull (University of Pittsburgh) and colleagues published a new review in Annual Review of Medicine on phage therapy for antibiotic-resistant bacterial Infections. They conclude that given the strong safety profiles of phages, the

Karen Fong (Summerland Research and Development Centre, Canada) and colleagues published a review article in PHAGE on the host range of phages and its impact on the agri-food sector. They discuss the research pro

Diana Pires (University of Minho, Portugal) and colleagues published a review in Annual Review of Virology on understanding the complex phage-host interactions in biofilm communities. They summarize the main features affecting phage-biofilm

Eleanor Townsend (University of Warwick) and colleagues published a new review in Frontiers in Cellular and Infection Microbiology on the origins and roles of phages in the human gut microbiome. They review phageome development in infancy a

Saartje Uyttebroek (UZ Leuven & KU Leuven) and colleagues published a new review in Antibiotics showing the potential role of phages in the treatment of recalcitrant chronic rhinosinusitis. They also discuss considerations for implementing

Medeea Popescu (Stanford University) and colleagues published a new review in Annual Review of Virology covering what is currently known about phages and the immune system.

Bridget Watson (University of Exeter) and colleagues published a new review in Cell Host & Microbe on coevolution between bacterial CRISPR-Cas systems and their phages. They discuss when and why CRISPR-Cas immunity against phages evolves, a

Adam Wahida (Technical University of Munich) and colleagues published a new minireview on phage-bacteria-eukaryotic relationships and their influence on human health.

Martin Loessner and Rob Lavigne co-edited a special issue of Current Opinion in Biotechnology dedicated to phage, entitled Nanobiotechnology — Phage Therapy. The issue is now complete: check out the 21 articles here!

Ahmad Hassan (Agriculture and Agri-Food Canada and University of Guelph) and colleagues published a new review on phages as both friends and foes in therapeutic and biocontrol applications. They first detail the reasons for the antimicrobia

Fatma Abdelrahman (Zewail City of Science and Technology, Egypt) and colleagues from 7 countries (Egypt, India, Nigeria, Australia, China, Pakistan, Spain), many of them early career researchers, published a new review in Antibiotics on pha

Yuping Li and Joseph Bondy-Denomy (University of California San Francisco) published a new review in Cell Host & Microbe discussing how anti-CRISPRs affect the ecology and evolution of bacteria and phage.

To use phages as therapeutic agents, ensuring phages reach the site of infection is key. Belinda Loh (Zhejiang University, China) and colleagues published a review article unfolding numerous approaches for phage delivery, including methods

Bryan Lenneman (Massachusetts Institute of Technology) and colleagues published a review on phage engineering approaches to redirect specificity and reduce resistance development. They also describe the application of designer phages as gen

Diana Pires (University of Minho) and colleagues published a review article describing the present-day challenges and opportunities in phage therapy, by analyzing the outcomes of trials and case reports done to date. Along with the current